Literature DB >> 1997408

Anti-Borrelia burgdorferi antibody response over the course of Lyme neuroborreliosis.

S Baig1, T Olsson, K Hansen, H Link.   

Abstract

Characteristic findings on examination of cerebrospinal fluid (CSF) in Lyme neuroborreliosis include mononuclear pleocytosis, oligoclonal immunoglobulin G (IgG) bands, and evidence for local production of specific antibodies. We utilized an immunospot assay to detect cells secreting anti-Borrelia burgdorferi antibodies of different isotypes over the course of disease. Such cells were detected in CSF from 13 consecutive patients with neuroborreliosis examined before treatment. IgG antibody-secreting cells were present in high numbers (mean, 32 cells per 10(4) CSF cells), whereas IgA and IgM antibody-secreting cells were found less frequently and at lower numbers (mean, 5 and 6 cells per 10(4) CSF cells, respectively). Clinical improvement after penicillin treatment was paralleled by a rapid decline of antibody-secreting cells in CSF, but they were still detected, although at lower numbers, in 5 of 10 patients examined more than 6 months after treatment. This specific B-cell response persisted despite clinical improvement. Whether it reflects persistence of antigen is unsettled.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997408      PMCID: PMC258366          DOI: 10.1128/iai.59.3.1050-1056.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Authors:  H Link; G Tibbling
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

2.  Neurologic abnormalities of Lyme disease.

Authors:  L Reik; A C Steere; N H Bartenhagen; R E Shope; S E Malawista
Journal:  Medicine (Baltimore)       Date:  1979-07       Impact factor: 1.889

3.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

4.  Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification.

Authors:  T Olsson; V Kostulas; H Link
Journal:  Clin Chem       Date:  1984-07       Impact factor: 8.327

5.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.

Authors:  C C Czerkinsky; L A Nilsson; H Nygren; O Ouchterlony; A Tarkowski
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Letter: Substitute for benzidine in myeloperoxidase stains.

Authors:  I S Kaplow
Journal:  Am J Clin Pathol       Date:  1975-03       Impact factor: 2.493

7.  Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  K Hansen; M Cruz; H Link
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

8.  Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome and lymphocytic meningoradiculitis by isoelectric focusing.

Authors:  H Krüger; D Englert; K W Pflughaupt
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

9.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

10.  Bannwarth's syndrome (lymphocytic meningoradiculitis) in Sweden.

Authors:  B Ryberg
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  9 in total

1.  Anti-purified protein derivative cell-enzyme-linked immunosorbent assay, a sensitive method for early diagnosis of tuberculous meningitis.

Authors:  S M Baig
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

2.  Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi.

Authors:  M Brunner; L H Sigal
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.

Authors:  E Fikrig; R Berland; M Chen; S Williams; L H Sigal; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

4.  Detection of oligoclonal IgA in cerebrospinal fluid samples by an isoelectric focusing procedure.

Authors:  W Withold; M Wick; A Fateh-Moghadam; K Einhäupl
Journal:  J Neurol       Date:  1994-03       Impact factor: 4.849

5.  Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.

Authors:  Marija Djukic; Carsten Schmidt-Samoa; Peter Lange; Annette Spreer; Katja Neubieser; Helmut Eiffert; Roland Nau; Holger Schmidt
Journal:  J Neurol       Date:  2011-09-06       Impact factor: 4.849

6.  Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.

Authors:  Tamara van Gorkom; Willem Voet; Gijs H J van Arkel; Michiel Heron; B J A Hoeve-Bakker; Daan W Notermans; Steven F T Thijsen; Kristin Kremer
Journal:  Microbiol Spectr       Date:  2022-06-21

Review 7.  Chronic Lyme disease: misconceptions and challenges for patient management.

Authors:  John J Halperin
Journal:  Infect Drug Resist       Date:  2015-05-15       Impact factor: 4.003

8.  Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis.

Authors:  Sebastian Rauer; Stephan Kastenbauer; Heidelore Hofmann; Volker Fingerle; Hans-Iko Huppertz; Klaus-Peter Hunfeld; Andreas Krause; Bernhard Ruf; Rick Dersch
Journal:  Ger Med Sci       Date:  2020-02-27

9.  Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases.

Authors:  Kunal Garg; Leena Meriläinen; Ole Franz; Heidi Pirttinen; Marco Quevedo-Diaz; Stephen Croucher; Leona Gilbert
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.